Mr Muharrem Okan Cakir

Research project: Potential therapeutic effects of natural products in Human Papillomavirus (HPV) related cancers




I received my BSc degree from Genetics and Bioengineering Department, University of Yeditepe, Turkey in 2015 before completing MSc in Drug Design and Biomedical Science, Edinburgh Napier University where I worked on androgen receptor variants in castrate resistant prostate cancer(CRPC). I have been mainly involved in biomedical research in cancer genetics and cancer drug discovery. Since 2019, I am doing my PhD in Anatomy, Physiology and Pathology at Kingston University, London.

Areas of research interest

  • Human Papilloma Virus (HPV) related cancers
  • Cancer Therapeutics
  • Viral Oncology
  • Genome editing


  • BSc in Genetics and Bioengineering, Yeditepe University,Turkey
  • MSc in Drug Design and Biomedical Science, Edinburgh Napier University, United Kingdom
  • Associate Fellowship in Higher Education Academy

Funding or awards received

  • Best Research Paper Award, Turkish Medical Oncology Congress, 2016
  • Kingston University Innovation Seedcorn Grant,2022
  • Kingston University Innovation Seedcorn Grant,2023


Hyperprogression after immunotherapy: A comprehensive review

Muharrem Okan Cakir, Onder Kirca, Seyda Gunduz, Mustafa Ozdogan; pp 2232-2241, JBUON,2019

Chemical synthesis of a library of natural product-like derivatives based on pinnaic acid and initial evaluation of their anti-cancer activity

Fudger, Alex, Cakir, Okan M., Khan, Yousaf, Sinclair, Alex and Le Gresley, Adam (2022),  Organic & Biomolecular Chemistry, ISSN (print) 1477-0520.

Comprehensive tumor molecular profile analysis in clinical practice.

Özdo?an M, Papadopoulou E, Tsoulos N, Tsantikidi A, Mariatou VM, Tsaousis G, Kapeni E, Bourkoula E, Fotiou D, Kapetsis G, Boukovinas I, Touroutoglou N, Fassas A, Adamidis A, Kosmidis P, Trafalis D, Galani E, Lypas G, Orhan B, Tansan S, Özatl? T, K?rca O, Cak?r O, Nasioulas G.  BMC Med Genomics. 2021 Apr 14;14(1):105. doi: 10.1186/s12920-021-00952-9. PMID: 33853586; PMCID: PMC8045191.

Detection of high-risk Human Papillomavirus in prostate cancer from a UK based population. 

Ahmed MY, Salman NA, Sandhu S, Cakir MO, Seddon AM, Kuehne C, Ashrafi GH.Sci Rep. 2023 May 10;13(1):7633. doi: 10.1038/s41598-023-34734-3. PMID: 37165210; PMCID: PMC10172334.